Health Care·Health Care Technology·$1.1B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-0.40 | N/A | -5.54% |
management commentary, guidance changes, and full analysis available with Pro.
| -5.54% |
Tone: Cautiously Optimistic
Overall, management expressed a cautious optimism about future growth opportunities. They acknowledged the current financial performance but focused on strategic investments.
Management emphasized the importance of long-term growth despite current challenges.
They highlighted ongoing investments in technology and customer engagement.
The earnings report indicates that Teladoc Health Inc is still facing challenges, particularly reflected in the EPS miss. The stock reacted slightly down by 0.17%, suggesting investor caution. Management's focus on long-term growth and technology investments may provide some reassurance, but the lack of guidance leaves uncertainty about future performance.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
TEVA PHARMACEUTICAL ADR
May 9, 2016